| ROP | Retinopathy of Prematurity |
| VEGF | Vascular Endothelial Growth Factor |
| IGF-I | Insulin-like Growth Factor |
| ACE | Angiotensin-Converting Enzyme |
| bFGF | Basic Fibroblast Growth Factor |
| TNF-α | Tumor Necrosis Factor-alpha |
| NO | Nitric Oxide |
| miRNA | MicroRNA |
| mRNA | Messenger RNA |
| OIR | Oxygen-Induced Retinopathy |
| PDGF | Platelet-Derived Growth Factor |
| RGC | Retinal Ganglion Cells |
| SEMA3E | Semaphorin 3E |
| CRYO-ROP | Cryotherapy for Retinopathy of Prematurity |
| ETROP | Early Treatment for Retinopathy of Prematurity |
| BEAT-ROP | Bevacizumab Eliminates the Angiogenic Threat of Retinopathy of Prematurity |
| RAINBOW | Ranibizumab Compared with Laser Therapy for ROP |
| PI3K | Phosphoinositide 3-Kinase |
| TGF-β | Transforming Growth Factor-beta |
| PPARγ | Peroxisome Proliferator-Activated Receptor Gamma |
| HIF1A | Hypoxia-Inducible Factor 1-alpha |